Indika Gawarammana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Indika Gawarammana has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
- Fahim Mohamed
South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
12 shared publications - Nicholas A. Buckley
School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
11 shared publications - Michael Eddleston
Centre for Pesticide Suicide Prevention, and Pharmacology, Toxicology and Therapeutics, Centre for Cardiovascular Science, University of Edinburgh
7 shared publications - Amal Dharmapriya Premarathna
School of Natural Sciences and Health, Tallinn University, Narva mnt 29, 10120 Tallinn, Estonia
4 shared publications - Andrew Hamilton Dawson
South Asian Clinical Toxicology Research Collaboration, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka
4 shared publications - Eranga Sanjeewa Wijewickrama
Department of Clinical Medicine, Faculty of Medicine, University of Colombo
4 shared publications
Latest Publications
- Open Access
- 26 May 2026
- Published by Sri Lanka Journals Online in Journal of Tropical Health
- Vol. 2 (1) , 9-23
A Multicenter Double-blind Randomised Parallel Group Phase Three Superiority Clinical Trial on the Effectiveness of Dextran 40 Compared to Normal Saline in Preventing Dengue Shock in the Early Leakage Phase of Dengue Haemorrhagic Fever: Study Protocol
Background: Dengue haemorrhagic fever (DHF) remains a major cause of morbidity in tropical countries, with progression to shock contributing substantially to mortality. Early plasma leakage with organ hypoperfusion may represent a critical therapeutic window for intervention. This study evaluates whether dextran-40 is superior to normal saline in preventing dengue shock during the early leakage phase of DHF.Methods: The Dextran in the Early Leakage Phase of Dengue Prevents Shock (DELPODS) study is a multicenter, double-blind, randomised, parallel-group phase III superiority trial conducted in Sri Lanka. Adults aged ≥18 years with confirmed dengue fever and evidence of early plasma leakage with organ hypoperfusion are randomised to receive either intravenous dextran-40 (5 mL/kg; maximum 250 mL) or 0.9% normal saline at an equivalent dose infused over 2 hours. Patients with advanced plasma leakage, established shock, pregnancy, acute kidney injury, advanced chronic kidney disease, severe heart failure, severe liver disease, or dextran hypersensitivity are excluded. The planned sample size is 218 participants.Outcomes: The primary outcome is the incidence of shock within 48 hours of randomisation. Secondary outcomes include maintenance of haemodynamic stability, time to haemodynamic instability, need for additional fluid therapy, clinical outcomes at discharge, and safety outcomes including fluid overload, acute kidney injury, and hypersensitivity reactions.Ethics and Registration: Ethical approval was obtained from the Ethics Review Committee of the Faculty of Medical & Allied Sciences, Rajarata University of Sri Lanka (22 June 2022). The trial is registered with the Sri Lanka Clinical Trial Registry (SLCTR/2022/003; U1111-1272-4389).
- 26 May 2026
- Published by Sri Lanka Journals Online in Journal of Tropical Health
- Vol. 2 (1) , 9-23
Open AccessA Multicenter Double-blind Randomised Parallel Group Phase Three Superiority Clinical Trial on the Effectiveness of Dextran 40 Compared to Normal Saline in Preventing Dengue Shock in the Early Leakage Phase of Dengue Haemorrhagic Fever: Study Protocol
Background: Dengue haemorrhagic fever (DHF) remains a major cause of morbidity in tropical countries, with progression to shock contributing substantially to mortality. Early plasma leakage with organ hypoperfusion may represent a critical therapeutic window for intervention. This study evaluates whether dextran-40 is superior to normal saline in preventing dengue shock during the early leakage phase of DHF.Methods: The Dextran in the Early Leakage Phase of Dengue Prevents Shock (DELPODS) study is a multicenter, double-blind, randomised, parallel-group phase III superiority trial conducted in Sri Lanka. Adults aged ≥18 years with confirmed dengue fever and evidence of early plasma leakage with organ hypoperfusion are randomised to receive either intravenous dextran-40 (5 mL/kg; maximum 250 mL) or 0.9% normal saline at an equivalent dose infused over 2 hours. Patients with advanced plasma leakage, established shock, pregnancy, acute kidney injury, advanced chronic kidney disease, severe heart failure, severe liver disease, or dextran hypersensitivity are excluded. The planned sample size is 218 participants.Outcomes: The primary outcome is the incidence of shock within 48 hours of randomisation. Secondary outcomes include maintenance of haemodynamic stability, time to haemodynamic instability, need for additional fluid therapy, clinical outcomes at discharge, and safety outcomes including fluid overload, acute kidney injury, and hypersensitivity reactions.Ethics and Registration: Ethical approval was obtained from the Ethics Review Committee of the Faculty of Medical & Allied Sciences, Rajarata University of Sri Lanka (22 June 2022). The trial is registered with the Sri Lanka Clinical Trial Registry (SLCTR/2022/003; U1111-1272-4389).
- Open Access
- 20 February 2026
- Published by Public Library of Science (PLoS) in PLOS Mental Health
- Vol. 3 (2) , e0000562
Brief psychological intervention for the prevention of deliberate self-poisoning: A randomized controlled trial from Sri Lanka
Previous work suggests that many nurses in Sri Lanka, particularly those who work in primary care, involved in the medical treatment of persons who attempt self-poisoning already approach their role holistically and consider ‘providing mental health support as a part of nursing. However, at present, nurses are not given formal training on the delivery of such support, nor has the efficacy or feasibility of such an intervention been assessed in Sri Lanka. A mixed-method design was employed: a pilot randomized controlled trial with embedded qualitative methods. Participants (n = 300) were admitted to Teaching Hospital Peradeniya after non-fatal self-poisoning incidents. The brief psychological intervention consisted of a counselling session that encouraged participants to explore alternative strategies for managing emotional distress and future stressors. Ward nurses received training to deliver the intervention to assigned patients. Quantitative and qualitative data were collected at baseline and follow-up. At the six-month follow-up, the trail demonstrated the intervention’s effectiveness in significantly reducing anxiety and promoting positive coping strategies, although no significant differences were observed in depression rates or alcohol use disorder. Qualitative interviews indicated that participants, found the counselling valuable for emotional support and guidance in managing future interpersonal conflicts and stressors. Overall, this study suggests that brief psychological interventions can support the mental health of those at risk of self-poisoning and encouraging alternative coping strategies. When offering mental health support to individuals who have attempted self-poisoning, it is more feasible to assign dedicated, trained nurses than to expect all nurses to contribute.
- 20 February 2026
- Published by Public Library of Science (PLoS) in PLOS Mental Health
- Vol. 3 (2) , e0000562
Open AccessBrief psychological intervention for the prevention of deliberate self-poisoning: A randomized controlled trial from Sri Lanka
Previous work suggests that many nurses in Sri Lanka, particularly those who work in primary care, involved in the medical treatment of persons who attempt self-poisoning already approach their role holistically and consider ‘providing mental health support as a part of nursing. However, at present, nurses are not given formal training on the delivery of such support, nor has the efficacy or feasibility of such an intervention been assessed in Sri Lanka. A mixed-method design was employed: a pilot randomized controlled trial with embedded qualitative methods. Participants (n = 300) were admitted to Teaching Hospital Peradeniya after non-fatal self-poisoning incidents. The brief psychological intervention consisted of a counselling session that encouraged participants to explore alternative strategies for managing emotional distress and future stressors. Ward nurses received training to deliver the intervention to assigned patients. Quantitative and qualitative data were collected at baseline and follow-up. At the six-month follow-up, the trail demonstrated the intervention’s effectiveness in significantly reducing anxiety and promoting positive coping strategies, although no significant differences were observed in depression rates or alcohol use disorder. Qualitative interviews indicated that participants, found the counselling valuable for emotional support and guidance in managing future interpersonal conflicts and stressors. Overall, this study suggests that brief psychological interventions can support the mental health of those at risk of self-poisoning and encouraging alternative coping strategies. When offering mental health support to individuals who have attempted self-poisoning, it is more feasible to assign dedicated, trained nurses than to expect all nurses to contribute.
- Open Access
- 4 March 2025
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 63 (4) , 236-245
Nephrotoxicity biomarkers following propanil (3,4-dichloropropionanilide) self-poisoning
Propanil toxicity is characterised by severe prolonged methaemoglobinaemia, cyanosis, acidosis, and progressive end-organ dysfunction. In vitro studies report propanil-induced kidney toxicity, which has not been studied clinically. This study determined the incidence of acute kidney injury and of methaemoglobinaemia after propanil self-poisoning and reported the diagnostic performance of novel and traditional biomarkers of acute kidney injury. Sixty-seven previously healthy patients were recruited following acute propanil self-poisoning, between October 2010 and October 2014. Concentrations of serum biomarkers and urine biomarkers normalised for urine creatinine excretion were measured. Plasma and urine concentrations of propanil, its main metabolite 3,4-dichloroaniline, the antidote methylthioninium chloride (methylene blue), and methaemoglobin levels were measured. Kidney biomarkers were measured in 52 of the 67 patients, with 40% developing acute kidney injury (stage 1 [32%] and stage 2 [8%]). Blood methaemoglobin levels were recorded in 23 patients. Normalised urine biomarker concentrations of kidney injury molecule-1, trefoil factor 3, neutrophil gelatinase-associated lipocalin and beta2 microglobulin increased in patients who developed acute kidney injury, but only trefoil factor 3 and cystatin C showed a significantly predicted acute kidney injury at 16-24 h and 8-16 h post-ingestion, respectively. In contrast, serum creatinine concentrations had a very good diagnostic performance throughout the 24 h post-ingestion period, with area under the receiver operating characteristic curve values of 0.79-0.96. Blood methaemoglobin levels were higher in patients with acute kidney injury and correlated with plasma propanil and 3,4-dichloroaniline concentrations. Concentrations of serum creatinine, urine beta2 microglobulin, and trefoil factor-3 significantly correlated with plasma and urine concentrations of propanil, 3,4-dichloroaniline, and methylthioninium chloride. Severe methaemoglobinaemia can impair oxygen delivery and may cause acute ischaemic kidney injury. The poor diagnostic performance of novel biomarkers may be attributed to non-renal factors influencing creatinine concentration or an unusual site or mechanism of nephrotoxicity after propanil poisoning. Patients with propanil self-poisoning exhibited reversible kidney injury diagnosable using serum creatinine concentrations within 4 h. Although other biomarkers were increased, they were not effective for early diagnosis.
- 4 March 2025
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 63 (4) , 236-245
Open AccessNephrotoxicity biomarkers following propanil (3,4-dichloropropionanilide) self-poisoning
Propanil toxicity is characterised by severe prolonged methaemoglobinaemia, cyanosis, acidosis, and progressive end-organ dysfunction. In vitro studies report propanil-induced kidney toxicity, which has not been studied clinically. This study determined the incidence of acute kidney injury and of methaemoglobinaemia after propanil self-poisoning and reported the diagnostic performance of novel and traditional biomarkers of acute kidney injury. Sixty-seven previously healthy patients were recruited following acute propanil self-poisoning, between October 2010 and October 2014. Concentrations of serum biomarkers and urine biomarkers normalised for urine creatinine excretion were measured. Plasma and urine concentrations of propanil, its main metabolite 3,4-dichloroaniline, the antidote methylthioninium chloride (methylene blue), and methaemoglobin levels were measured. Kidney biomarkers were measured in 52 of the 67 patients, with 40% developing acute kidney injury (stage 1 [32%] and stage 2 [8%]). Blood methaemoglobin levels were recorded in 23 patients. Normalised urine biomarker concentrations of kidney injury molecule-1, trefoil factor 3, neutrophil gelatinase-associated lipocalin and beta2 microglobulin increased in patients who developed acute kidney injury, but only trefoil factor 3 and cystatin C showed a significantly predicted acute kidney injury at 16-24 h and 8-16 h post-ingestion, respectively. In contrast, serum creatinine concentrations had a very good diagnostic performance throughout the 24 h post-ingestion period, with area under the receiver operating characteristic curve values of 0.79-0.96. Blood methaemoglobin levels were higher in patients with acute kidney injury and correlated with plasma propanil and 3,4-dichloroaniline concentrations. Concentrations of serum creatinine, urine beta2 microglobulin, and trefoil factor-3 significantly correlated with plasma and urine concentrations of propanil, 3,4-dichloroaniline, and methylthioninium chloride. Severe methaemoglobinaemia can impair oxygen delivery and may cause acute ischaemic kidney injury. The poor diagnostic performance of novel biomarkers may be attributed to non-renal factors influencing creatinine concentration or an unusual site or mechanism of nephrotoxicity after propanil poisoning. Patients with propanil self-poisoning exhibited reversible kidney injury diagnosable using serum creatinine concentrations within 4 h. Although other biomarkers were increased, they were not effective for early diagnosis.
- Open Access
- 3 March 2025
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 18 (1) , 2468782
Impact of a clinical pharmacy intervention on medication adherence and the quality use of medicines in patients with acute coronary syndrome: a single centre nonrandomised controlled clinical trial
Acute coronary syndrome is a major global disease burden with high morbidity and mortality. This study aims to assess the impact of clinical pharmacy interventions on improving the quality use of medicines and drug-related problems in acute coronary syndrome patients. An open, prospective, controlled, nonrandomised clinical trial was conducted at the Teaching Hospital, Peradeniya, Sri Lanka. Consenting patients were recruited and divided into control and intervention groups. Medication history, medication adherence and drug-related problems were assessed. The intervention group received clinical pharmacy interventions for six months. Improvements in medication adherence, discharge medication appropriateness, reduction of hospital readmissions for six months, and responses from the healthcare team’s awareness and perception on clinical pharmacy services were recorded. Both groups (control – 180 patients, intervention – 185 patients) showed poor medication adherence at baseline. Medication adherence improved significantly after 6-months post-discharge in the intervention group compared to the control group (49.3% vs 18.8%). The clinical pharmacists successfully identified drug-related problems and provided suggestions for resolving them. The treating team accepted the majority (60%) of these suggestions. Discharge medication appropriateness in the intervention group was significantly higher compared to the control group. There was no significant difference in hospital readmissions related to cardiovascular disorders between the groups. Most doctors and nurses were aware of clinical pharmacists but none of them had previously worked with one. Clinical pharmacist-led interventions significantly improved medication adherence and appropriateness, underscoring the added value of clinical pharmacists in a multidisciplinary healthcare team. While most doctors and nurses were aware of clinical pharmacists, none of them had prior experience working with them, emphasising an opportunity to foster greater multidisciplinary integration for improved health outcomes. Overall findings highlight the potential role of clinical pharmacists in enhancing good patient outcomes and improving real-world patient care.
- 3 March 2025
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 18 (1) , 2468782
Open AccessImpact of a clinical pharmacy intervention on medication adherence and the quality use of medicines in patients with acute coronary syndrome: a single centre nonrandomised controlled clinical trial
Acute coronary syndrome is a major global disease burden with high morbidity and mortality. This study aims to assess the impact of clinical pharmacy interventions on improving the quality use of medicines and drug-related problems in acute coronary syndrome patients. An open, prospective, controlled, nonrandomised clinical trial was conducted at the Teaching Hospital, Peradeniya, Sri Lanka. Consenting patients were recruited and divided into control and intervention groups. Medication history, medication adherence and drug-related problems were assessed. The intervention group received clinical pharmacy interventions for six months. Improvements in medication adherence, discharge medication appropriateness, reduction of hospital readmissions for six months, and responses from the healthcare team’s awareness and perception on clinical pharmacy services were recorded. Both groups (control – 180 patients, intervention – 185 patients) showed poor medication adherence at baseline. Medication adherence improved significantly after 6-months post-discharge in the intervention group compared to the control group (49.3% vs 18.8%). The clinical pharmacists successfully identified drug-related problems and provided suggestions for resolving them. The treating team accepted the majority (60%) of these suggestions. Discharge medication appropriateness in the intervention group was significantly higher compared to the control group. There was no significant difference in hospital readmissions related to cardiovascular disorders between the groups. Most doctors and nurses were aware of clinical pharmacists but none of them had previously worked with one. Clinical pharmacist-led interventions significantly improved medication adherence and appropriateness, underscoring the added value of clinical pharmacists in a multidisciplinary healthcare team. While most doctors and nurses were aware of clinical pharmacists, none of them had prior experience working with them, emphasising an opportunity to foster greater multidisciplinary integration for improved health outcomes. Overall findings highlight the potential role of clinical pharmacists in enhancing good patient outcomes and improving real-world patient care.
- 14 January 2025
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 63 (2) , 83-91
The relationships of plasma profenofos and ethanol concentrations to clinical outcome in acute profenofos self-poisoning
Many patients acutely self-poisoned with organophosphorus insecticides have co-ingested ethanol. Currently, profenofos 50% emulsifiable concentrate (EC50) is commonly ingested for self-harm in Sri Lanka. Clinical experience suggests that ethanol co-ingestion makes management more difficult. Therefore, we aimed to determine the relationships between plasma ethanol concentration, plasma profenofos concentration and its toxicokinetics, and clinical outcome in acute profenofos self-poisoning. Demographic and clinical data, including a history of ethanol ingestion and blood samples, were prospectively collected from all cases of acute poisoning with profenofos EC50 presenting to Teaching Hospital Peradeniya, Sri Lanka, over four years. Plasma samples were analyzed by gas chromatography-mass spectrometry to quantify the ethanol (n = 99) and profenofos (n = 30 [15 with ethanol, 15 without ethanol]) concentrations. The PKSolver program was used to calculate the toxicokinetic parameters. Of 99 patients (male 78/99) with acute profenofos self-poisoning, 50 reported a history of ethanol co-ingestion. Plasma from 44 of 99 profenofos-poisoned patients had detectable ethanol concentrations. No statistical difference was observed between the mortality in the ethanol group and the no ethanol group (5/44 [11.4%] versus 3/55 [5.5%]; P = 0.461). Similarly, the median half-lives of plasma profenofos absorption in the ethanol and no ethanol groups (0.1 h and 0.1 h, respectively; time 0-24 h) were not statistically different (P = 0.6594). However, the median half-life of plasma profenofos elimination was significantly longer in the ethanol group than the no ethanol group (23.1 h and 9.9 h, respectively; time 0-24 h; P = 0.0002). According to the regression analysis, the half-life of plasma profenofos elimination was longer by 29.4 h in the ethanol group (P = 0.013). No significant differences in outcomes, including death and endotracheal intubation rates, were found between those who did and did not co-ingest ethanol. No differences were found in toxicokinetic variables between the ethanol and no ethanol groups, but the ethanol group had a longer elimination half-life. The co-ingestion of ethanol leads to a slowing of the elimination kinetics of profenofos. However, the study did not reveal a significant impact of ethanol co-ingestion on clinical outcomes.
- 14 January 2025
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 63 (2) , 83-91
The relationships of plasma profenofos and ethanol concentrations to clinical outcome in acute profenofos self-poisoning
Many patients acutely self-poisoned with organophosphorus insecticides have co-ingested ethanol. Currently, profenofos 50% emulsifiable concentrate (EC50) is commonly ingested for self-harm in Sri Lanka. Clinical experience suggests that ethanol co-ingestion makes management more difficult. Therefore, we aimed to determine the relationships between plasma ethanol concentration, plasma profenofos concentration and its toxicokinetics, and clinical outcome in acute profenofos self-poisoning. Demographic and clinical data, including a history of ethanol ingestion and blood samples, were prospectively collected from all cases of acute poisoning with profenofos EC50 presenting to Teaching Hospital Peradeniya, Sri Lanka, over four years. Plasma samples were analyzed by gas chromatography-mass spectrometry to quantify the ethanol (n = 99) and profenofos (n = 30 [15 with ethanol, 15 without ethanol]) concentrations. The PKSolver program was used to calculate the toxicokinetic parameters. Of 99 patients (male 78/99) with acute profenofos self-poisoning, 50 reported a history of ethanol co-ingestion. Plasma from 44 of 99 profenofos-poisoned patients had detectable ethanol concentrations. No statistical difference was observed between the mortality in the ethanol group and the no ethanol group (5/44 [11.4%] versus 3/55 [5.5%]; P = 0.461). Similarly, the median half-lives of plasma profenofos absorption in the ethanol and no ethanol groups (0.1 h and 0.1 h, respectively; time 0-24 h) were not statistically different (P = 0.6594). However, the median half-life of plasma profenofos elimination was significantly longer in the ethanol group than the no ethanol group (23.1 h and 9.9 h, respectively; time 0-24 h; P = 0.0002). According to the regression analysis, the half-life of plasma profenofos elimination was longer by 29.4 h in the ethanol group (P = 0.013). No significant differences in outcomes, including death and endotracheal intubation rates, were found between those who did and did not co-ingest ethanol. No differences were found in toxicokinetic variables between the ethanol and no ethanol groups, but the ethanol group had a longer elimination half-life. The co-ingestion of ethanol leads to a slowing of the elimination kinetics of profenofos. However, the study did not reveal a significant impact of ethanol co-ingestion on clinical outcomes.
- 22 November 2024
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 119 (5) , 453-463
Is therapeutic plasma exchange effective in leptospirosis-associated severe pulmonary haemorrhagic syndrome? A systematic review
Leptospirosis is a re-emerging zoonosis fast becoming a global burden. Pulmonary haemorrhages are a deadly complication, with case fatality rates >50%. Systemic vasculitis is thought to be the pathological process responsible for pulmonary haemorrhages and therapeutic plasma exchange (TPE) is one of the treatments offered. This systematic review aims to evaluate the effectiveness of TPE in managing leptospirosis-associated severe pulmonary haemorrhagic syndrome (SPHS). A systematic review was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis protocol. The search used Medical Subject Headings in PubMed with keywords ‘Leptospirosis’ OR ‘Leptospira’ OR ‘Weil disease’ AND ‘plasmapheresis’ OR ‘plasma exchange’ AND ‘pulmonary haemorrhage’ OR ‘alveolar haemorrhage’. The search was widened to include the Google Scholar database. The review was confined to English-language articles and focused on primary research studies. Nineteen articles were considered for analysis. There were no randomized controlled trials. A non-randomized trial and a retrospective cohort documented recovery following adjuvant TPE treatment. Most case reports mention significant improvement and complete recovery following administration of TPE. One case reported the death of a patient despite treatment. However, this review revealed a lack of strong evidence endorsing the routine application of TPE as a therapeutic intervention for cases of SPHS. Thus we recommend the initiation of a well-structured randomized controlled trial to ensure an accurate assessment of the efficacy of TPE.
- 22 November 2024
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 119 (5) , 453-463
Is therapeutic plasma exchange effective in leptospirosis-associated severe pulmonary haemorrhagic syndrome? A systematic review
Leptospirosis is a re-emerging zoonosis fast becoming a global burden. Pulmonary haemorrhages are a deadly complication, with case fatality rates >50%. Systemic vasculitis is thought to be the pathological process responsible for pulmonary haemorrhages and therapeutic plasma exchange (TPE) is one of the treatments offered. This systematic review aims to evaluate the effectiveness of TPE in managing leptospirosis-associated severe pulmonary haemorrhagic syndrome (SPHS). A systematic review was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis protocol. The search used Medical Subject Headings in PubMed with keywords ‘Leptospirosis’ OR ‘Leptospira’ OR ‘Weil disease’ AND ‘plasmapheresis’ OR ‘plasma exchange’ AND ‘pulmonary haemorrhage’ OR ‘alveolar haemorrhage’. The search was widened to include the Google Scholar database. The review was confined to English-language articles and focused on primary research studies. Nineteen articles were considered for analysis. There were no randomized controlled trials. A non-randomized trial and a retrospective cohort documented recovery following adjuvant TPE treatment. Most case reports mention significant improvement and complete recovery following administration of TPE. One case reported the death of a patient despite treatment. However, this review revealed a lack of strong evidence endorsing the routine application of TPE as a therapeutic intervention for cases of SPHS. Thus we recommend the initiation of a well-structured randomized controlled trial to ensure an accurate assessment of the efficacy of TPE.
- Open Access
- 6 August 2024
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 18 (2) , 80-84
Hyponatraemia in stroke patients: A single-centre prospective cohort study.
Cerebral salt wasting syndrome (CSWS) and syndrome of inappropriate anti diuretic hormone secretion (SIADH) are the most common aetiological factors for developing hyponatremia following stroke. The differentiation of these two entities is crucial as the treatment options are completely different. The aim of this study is to determine the incidence of aetiologies of hyponatremia and compare demographic, clinical, imaging and laboratory parameters in each groupTwo hundred and forty-six patients with confirmed strokes were prospectively observed throughout the hospital stay in a tertiary referral center in Sri Lanka to identify the possible predictors of CSWS. Hyponatremia was defined as a serum Na+ level less than 131mmo/l. Serum osmolality, urine osmolality, urinary Na+, serum cortisol and thyroid function tests were performed on all the hyponatremic patients. The CSWS and SIADH were differentiated based on physical examination findings and laboratory parameters.The incidence of hyponatremia in our study population was 19.1% (95% Confidence interval, 14.39-24.58). The majority of patients (24, 51%) were attributed to CSWS. SIADH group comprised of 17 (36.2%) patients and 6 (12.7%) patients had other undetermined causes.The incidence of CSWS is higher than the incidence of SIADH among stroke patients in our setting.
- 6 August 2024
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 18 (2) , 80-84
Open AccessHyponatraemia in stroke patients: A single-centre prospective cohort study.
Cerebral salt wasting syndrome (CSWS) and syndrome of inappropriate anti diuretic hormone secretion (SIADH) are the most common aetiological factors for developing hyponatremia following stroke. The differentiation of these two entities is crucial as the treatment options are completely different. The aim of this study is to determine the incidence of aetiologies of hyponatremia and compare demographic, clinical, imaging and laboratory parameters in each groupTwo hundred and forty-six patients with confirmed strokes were prospectively observed throughout the hospital stay in a tertiary referral center in Sri Lanka to identify the possible predictors of CSWS. Hyponatremia was defined as a serum Na+ level less than 131mmo/l. Serum osmolality, urine osmolality, urinary Na+, serum cortisol and thyroid function tests were performed on all the hyponatremic patients. The CSWS and SIADH were differentiated based on physical examination findings and laboratory parameters.The incidence of hyponatremia in our study population was 19.1% (95% Confidence interval, 14.39-24.58). The majority of patients (24, 51%) were attributed to CSWS. SIADH group comprised of 17 (36.2%) patients and 6 (12.7%) patients had other undetermined causes.The incidence of CSWS is higher than the incidence of SIADH among stroke patients in our setting.
- Open Access
- 1 May 2023
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 17 (1) , 62
Biochemical factors involved in the pathophysiology of cerebral salt wasting syndrome following subarachnoid haemorrhage
- 1 May 2023
- Published by Sri Lanka Journals Online in Anuradhapura Medical Journal
- Vol. 17 (1) , 62
Open AccessBiochemical factors involved in the pathophysiology of cerebral salt wasting syndrome following subarachnoid haemorrhage
- Open Access
- 21 December 2022
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 61 (1) , 29-38
Dose ingested, vomiting, and outcome in patients ingesting a standard paraquat 20SL formulation
FAO specifications for liquid paraquat dichloride SL formulations require the use of an emetic agent to stimulate vomiting within 30 min of ingestion. To date, there is no high-quality evidence of ...
- 21 December 2022
- Published by Taylor & Francis in Clinical Toxicology
- Vol. 61 (1) , 29-38
Open AccessDose ingested, vomiting, and outcome in patients ingesting a standard paraquat 20SL formulation
FAO specifications for liquid paraquat dichloride SL formulations require the use of an emetic agent to stimulate vomiting within 30 min of ingestion. To date, there is no high-quality evidence of ...